122 related articles for article (PubMed ID: 5020280)
1. Effects of uraemic serum, urea, creatinine and methylguanidine on glucose metabolism.
Balestri PL; Rindi P; Biagini M; Giovannetti S
Clin Sci; 1972 Apr; 42(4):395-404. PubMed ID: 5020280
[No Abstract] [Full Text] [Related]
2. The red blood cell as a model for the study of uremic toxins.
Smith EK; Welt LG
Arch Intern Med; 1970 Nov; 126(5):827-30. PubMed ID: 4248903
[No Abstract] [Full Text] [Related]
3. The effect of guanidino substances from uremic plasma on insulin binding to erythrocyte receptors in uremia.
Rocić B; Breyer D; Granić M; Milutinović S
Horm Metab Res; 1991 Oct; 23(10):490-4. PubMed ID: 1761280
[TBL] [Abstract][Full Text] [Related]
4. Methylguanidine and insulin response in patients on maintenance haemodialysis.
Ferrannini E; Navalesi R; Pilo A; Morelli E
Lancet; 1976 Nov; 2(7993):1028-9. PubMed ID: 62253
[No Abstract] [Full Text] [Related]
5. Uremic toxins.
Balestri PL; Biagini M; Rindi P; Giovannetti S
Arch Intern Med; 1970 Nov; 126(5):843-5. PubMed ID: 5475707
[No Abstract] [Full Text] [Related]
6. [The effect of some "uremic toxins" on the renal production of ammonia].
Tizianello A; De Ferrari G; Garibotto G; Gurreri G; Acquarone N; Bruzzone M
Minerva Nefrol; 1976; 23(2):79-82. PubMed ID: 1004795
[No Abstract] [Full Text] [Related]
7. Guanidino compounds in uraemic dialysed patients.
De Deyn P; Marescau B; Lornoy W; Becaus I; Lowenthal A
Clin Chim Acta; 1986 Jun; 157(2):143-50. PubMed ID: 3719996
[TBL] [Abstract][Full Text] [Related]
8. The response to intravenous glucose of patients on maintenance hemodialysis: effects of dialysis.
Ferrannini E; Pilo A; Tuoni M
Metabolism; 1979 Feb; 28(2):125-36. PubMed ID: 763147
[TBL] [Abstract][Full Text] [Related]
9. [Dialysis of methylguanidine and hypothesis on the middle molecules].
Barsotti G; Giovannetti S
Ateneo Parmense Acta Biomed; 1975; 46(5):317-30. PubMed ID: 1232993
[TBL] [Abstract][Full Text] [Related]
10. Removal by dialysis of methylguanidine from body fluids.
Barsotti G; Giovannetti S
Proc Eur Dial Transplant Assoc; 1975; 11():105-11. PubMed ID: 1197242
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological studies on -guanidinobutyramide.
Buckle AL; Jones HE
Horm Metab Res; 1971 Mar; 3(2):76-81. PubMed ID: 4941848
[No Abstract] [Full Text] [Related]
12. Dialysis of methylguanidine.
Giovannetti S; Barsotti G
Kidney Int; 1974 Sep; 6(3):177-83. PubMed ID: 4425483
[No Abstract] [Full Text] [Related]
13. [Studies on the significance of middle molecular retention products as uremia toxins].
Goubeaud G; Leber HW; Schott HH
Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1244-6. PubMed ID: 611827
[No Abstract] [Full Text] [Related]
14. Abnormal carbohydrate metabolism in uraemia. Some properties of the inhibitor of glucose utilization present in the serum of uraemic patients.
Dzúrik R; Hupková V; Holomán J; Valovicová E
Int Urol Nephrol; 1971; 3(4):409-13. PubMed ID: 5154870
[No Abstract] [Full Text] [Related]
15. Growth hormone levels in severe renal failure.
Samaan NA; Freeman RM
Metabolism; 1970 Feb; 19(2):102-13. PubMed ID: 5410941
[No Abstract] [Full Text] [Related]
16. The effect of dialysis on true plasma glucose tolerance in uremia.
Weisinger JR; Reaven GM; Coplon NS; Swenson RS
Trans Am Soc Artif Intern Organs; 1973; 19():277-81. PubMed ID: 4722743
[No Abstract] [Full Text] [Related]
17. Serum guanidino compound levels in uremic pediatric patients treated with hemodialysis or continuous cycle peritoneal dialysis. Correlations between nerve conduction velocities and altered guanidino compound concentrations.
De Deyn PP; Robitaille P; Vanasse M; Qureshi IA; Marescau B
Nephron; 1995; 69(4):411-7. PubMed ID: 7777105
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of plasma from uraemic patients on human mononuclear phagocytes cultured in vitro.
Jorstad S; Viken KE
Acta Pathol Microbiol Scand C; 1977 Jun; 85(3):169-77. PubMed ID: 327752
[TBL] [Abstract][Full Text] [Related]
19. The effects of uremic compounds on cardiac function and metabolism.
Scheuer J; Stezoski W
J Mol Cell Cardiol; 1973 Jun; 5(3):287-300. PubMed ID: 4720519
[No Abstract] [Full Text] [Related]
20. Inhibitory effect of methylguanidine on insulin binding to its receptor. Mechanism underlying insulin resistance in uremia.
Lee JY; Iwama N; Watarai T; Yamasaki Y; Kawamori R; Kamada T
Diabetes Res Clin Pract; 1991 Sep; 13(3):173-80. PubMed ID: 1959480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
